Monday, December 23, 2024

Dis-Chem: my pick in the sector

Dis-Chem has several growth levers and seems to be pulling all of them, delivering a strong result in FY22.

Clicks is struggling in wholesale

The Clicks share price is flat this year, so it's been a much better investment than the US tech companies that the market got too excited about in 2021

Netcare is the perfect example of operating leverage

In a voluntary trading update for the six months to March 2022, Netcare announced that it achieved revenue growth of between 2% and 2.5%.

Mediclinic doing well in the recovery room

Mediclinic has provided a trading update for the year ended March 2022. With full results scheduled for release on 25 May, this gives the market a taste of what happened in that period

Life’s EBITDA margin is a mixed bag

Life Healthcare has released a voluntary trading update for the six months to March 2022. This covers the first half of the 2022 financial year.

Ascendis: more info on the businesses for sale

Ascendis Health has given further information on the financial information of the businesses that form part of the proposed disposal plan.
Verified by MonsterInsights